Acadian Asset Management
PTLA

Acadian Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Acadian Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-109
Closed -$6K – 1541
2015
Q4 		$6K Buy
+109
New +$5.29K ﹤0.01% 1295

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Acadian Asset Management's PTLA Position: Q1 2016 in Review

Acadian Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 109 shares — an estimated $6K sold.

Acadian Asset Management first reported a position in PTLA in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

  • Acadian Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Acadian Asset Management sold 109 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $6K.
  • Acadian Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 1 quarter.
  • Acadian Asset Management's Portola Pharmaceuticals, Inc. position peaked at $6K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Acadian Asset Management's 13F filing for Q1 2016, filed 14 Apr 2016.